PRESS RELEASE published on 02/13/2025 at 15:30, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.42% ownership in Direct Line Insurance Group plc per Form 8.3 filing on 13-Feb-2025 Form 8.3 Financial Filing Vanguard Group Ownership Disclosure Direct Line Insurance
BRIEF published on 02/11/2025 at 15:22, 1 year 6 months ago Disclosure of Vanguard's Stake in Direct Line Insurance Takeover Code Vanguard Group Stake Disclosure Direct Line Insurance Securities Interests
BRIEF published on 02/11/2025 at 15:22, 1 year 6 months ago Divulgation de la participation de Vanguard dans Direct Line Insurance Groupe Vanguard Code De Prise De Contrôle Divulgation Des Enjeux Intérêts En Matière De Valeurs Mobilières Assurance Ligne Directe
PRESS RELEASE published on 02/11/2025 at 15:17, 1 year 6 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.45% ownership in Direct Line Insurance Group plc as of 10 Feb 2025 Takeover Code Vanguard Group Ownership Disclosure Financial Disclosure Direct Line Insurance
BRIEF published on 02/10/2025 at 15:38, 1 year 7 months ago Vanguard Discloses Position in Direct Line Insurance Group Takeover Code Vanguard Group Share Disclosure Stakeholding Direct Line
BRIEF published on 02/10/2025 at 15:38, 1 year 7 months ago Vanguard dévoile sa position dans Direct Line Insurance Group Participation Groupe Vanguard Code De Prise De Contrôle Divulgation Des Partages Ligne Directe
PRESS RELEASE published on 02/10/2025 at 15:33, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.45% stake in Direct Line Insurance Group plc as of 07 February 2025 under Rule 8.3 of the Takeover Code Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Direct Line Insurance Group Plc
BRIEF published on 02/07/2025 at 15:20, 1 year 7 months ago The Vanguard Group's Disclosure on Direct Line Insurance Stake Ordinary Shares Takeover Code Vanguard Group Shareholding Disclosure Direct Line Insurance
BRIEF published on 02/07/2025 at 15:20, 1 year 7 months ago Divulgation par le groupe Vanguard de sa participation dans Direct Line Insurance Groupe Vanguard Actions Ordinaires Code De Prise De Contrôle Divulgation Des Actions Assurance Ligne Directe
PRESS RELEASE published on 02/07/2025 at 15:15, 1 year 7 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. disclosed a 5.45% ownership in Direct Line Insurance Group plc's 10 10/11p ordinary securities with purchase transactions Securities Vanguard Group Ownership Disclosure Direct Line Insurance Purchase Transactions
Published on 09/11/2026 at 04:00, 7 hours 6 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 41 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 46 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 6 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 51 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 46 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 1 minute ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 6 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 6 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 6 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 36 minutes ago Availability of the 2026 Interim Financial Report
